Back to Authors

Wang, Yucai

https://orcid.org/0000-0002-1576-8341

A5102945222 | I1330342723

Mayo Clinic

Citations 302

Incidence of Second Primary Malignancies in Lymphoma Survivors: A Prospective Cohort Study in the Modern Treatment Era

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1934-1936

10.1182/blood-2022-165207

Outcomes with Immunochemotherapy Plus Radiation Versus Immunochemotherapy Alone in Stage I Diffuse Large B-Cell Lymphoma: A Retrospective Study

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3829-3830

10.1182/blood-2022-171148

Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12390-12392

10.1182/blood-2022-165508

Clinical Outcomes in Patients with Mantle Cell Lymphoma Who Received Autologous Stem Cell Transplant in the Second Line Setting

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6517-6519

10.1182/blood-2022-165419

Molecular Landscape of Primary Refractory DLBCL

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9221-9223

10.1182/blood-2022-156497

Outcomes and Prognostic Factors of Transformed Follicular Lymphoma: An Analysis from the LEO Consortium

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6642-6644

10.1182/blood-2022-157083

Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory Mantle Cell Lymphoma: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9368-9372

10.1182/blood-2022-159425

Treatment Patterns and Outcomes in Relapsed/Refractory Mantle Cell Lymphoma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6489-6491

10.1182/blood-2022-167633

Performance of Glomerular Filtration Rate Estimating Equations in Cancer Patients Evaluated for Chimeric Antigen Receptor T-Cell Therapy

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10942-10944

10.1182/blood-2022-164785

FLIPI24: An Improved International Prognostic Model Developed on Early Events in Follicular Lymphoma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2292-2295

10.1182/blood-2022-157194